Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.140
-0.030 (-2.56%)
Sep 4, 2026, 11:38 AM EDT - Market open
BDMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24.49 | 22.54 | 37.04 | 31.46 | 35.09 | 29.7 | |
Revenue Growth | -23.12% | -39.15% | 17.73% | -10.35% | 18.16% | 63.92% |
Cost of Revenue | 3.52 | 3.65 | 4.38 | 4.23 | 7.05 | 5.03 |
Gross Profit | 20.97 | 18.88 | 32.65 | 27.23 | 28.04 | 24.67 |
Selling, General & Admin | 20.96 | 24.38 | 11.16 | 11.09 | 10.55 | 8.64 |
Research & Development | 14.34 | 20.13 | 6.17 | 4.27 | 3.86 | 1.54 |
Other Operating Expenses | - | - | - | - | - | 0.31 |
Operating Expenses | 35.31 | 44.51 | 17.34 | 15.37 | 14.41 | 10.07 |
Operating Income | -14.33 | -25.63 | 15.32 | 11.86 | 13.63 | 14.6 |
Interest Expense | -0.71 | -0.74 | -0.58 | -0.29 | -0.3 | -0.15 |
Interest & Investment Income | 0.02 | 0 | 0 | 0 | 0.01 | 0 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.05 |
Other Non Operating Income (Expenses) | 0.02 | -0.01 | -0.65 | 0.78 | 1.18 | -0.98 |
EBT Excluding Unusual Items | -15 | -26.37 | 14.09 | 12.36 | 14.52 | 13.52 |
Other Unusual Items | - | - | - | - | - | 0.79 |
Pretax Income | -15 | -26.37 | 14.09 | 12.36 | 14.52 | 14.32 |
Income Tax Expense | 1.17 | 1.17 | 1.49 | 1.7 | 1.75 | 2.53 |
Earnings From Continuing Operations | -16.17 | -27.54 | 12.6 | 10.66 | 12.77 | 11.78 |
Minority Interest in Earnings | 0.26 | 0.26 | -0.14 | -0.11 | -0.21 | -0.1 |
Net Income | -15.91 | -27.28 | 12.45 | 10.55 | 12.57 | 11.68 |
Net Income to Common | -15.91 | -27.28 | 12.45 | 10.55 | 12.57 | 11.68 |
Net Income Growth | - | - | 18.09% | -16.09% | 7.60% | 64.54% |
Shares Outstanding (Basic) | - | 28 | 22 | 21 | 26 | 1,181 |
Shares Outstanding (Diluted) | - | 28 | 22 | 21 | 26 | 1,181 |
Shares Change | - | 27.33% | 6.02% | -19.44% | -97.84% | - |
EPS (Basic) | - | -0.98 | 0.57 | 0.51 | 0.49 | 0.01 |
EPS (Diluted) | - | -0.98 | 0.57 | 0.51 | 0.49 | 0.01 |
EPS Growth | - | - | 11.77% | 4.08% | 4853.49% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -1.39 | -9.17 | -3.66 | -5.42 | 5.92 |
Free Cash Flow Per Share | - | -0.05 | -0.42 | -0.18 | -0.21 | 0.01 |
Gross Margin | 85.63% | 83.79% | 88.17% | 86.56% | 79.90% | 83.08% |
Operating Margin | -58.52% | -113.73% | 41.35% | 37.71% | 38.85% | 49.16% |
Profit Margin | -64.94% | -121.04% | 33.62% | 33.52% | 35.82% | 39.33% |
Free Cash Flow Margin | - | -6.15% | -24.75% | -11.63% | -15.46% | 19.95% |
EBITDA | -13.28 | -24.53 | 16.45 | 12.88 | 14.55 | 15.42 |
EBITDA Margin | -54.20% | -108.83% | 44.43% | 40.93% | 41.46% | 51.91% |
D&A For EBITDA | 1.06 | 1.1 | 1.14 | 1.01 | 0.92 | 0.82 |
EBIT | -14.33 | -25.63 | 15.32 | 11.86 | 13.63 | 14.6 |
EBIT Margin | -58.52% | -113.73% | 41.35% | 37.71% | 38.85% | 49.16% |
Effective Tax Rate | - | - | 10.57% | 13.76% | 12.03% | 17.69% |